TRICIDA ALERT: Bragar Eagel & Squire, P.C. is Investigating Tricida, Inc. on Behalf of Tricida Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tricida, Inc. (NADSAQ: TCDA) on behalf of Tricida stockholders. Our investigation concerns whether Tricida has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On July 15, 2020, Tricida issued a press release announcing “that on July 14, 2020, the Company received a notification from the U.S. Food and Drug Administration (FDA) stating that, as part of its ongoing review of the Company’s New Drug Application (NDA)” for Tricida’s drug candidate, veverimer (TRC101), “the FDA has identified deficiencies that preclude discussion of labeling and postmarketing requirements/commitments at this time.” Tricida stated that “[t]he notification does not specify the deficiencies identified by the FDA.”
On this news, Tricida’s stock price fell sharply on July 16, 2020, to close at $15.64 per share.
If you purchased or otherwise acquired Tricida shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato or Marion Passmore by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Originally Published on : http://www.globenewswire.com/news-release/2020/09/01/2086540/0/en/TRICIDA-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Tricida-Inc-on-Behalf-of-Tricida-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html
Contact/WhatsAPP: +91 7827887720 EMAIL: [email protected]
Disclaimer: The perspectives communicated in the article/news/press release above are those of the writers’ and don’t really speak to or mirror the perspectives of this website or its personnel. Except if in any case noticed, the writer is writing in his/her own ability. They are not expected and ought not to be thought to speak to legitimate thoughts, perspectives, or strategies of any individual, Institution, organization or foundation.